🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study in adults with advanced solid tumors including non-small ce...
Status
Completed
Location
University of Miami
Start Date
2017-06-13
Trial ID
NCT03156114
Treatments Being Tested
The goal of this observational study is to measure and try to reduce leakag...
Status
Not Yet Recruiting
Location
Carolina Blood and Cancer Care Associates
Start Date
2024-10-18
Trial ID
NCT06090513
This phase III trial studies how well combination chemotherapy, bevacizumab...
Status
Active Not Recruiting
Location
Kingman Regional Medical Center
Start Date
2018-01-19
Trial ID
NCT02997228
This study is a single-center prospective exploratory research, aiming to i...
Status
Recruiting
Location
Jian Li
Start Date
2024-01-10
Trial ID
NCT06549907
Treatments Being Tested
This is a first-in-human, open label, multicenter, dose escalation study of...
Status
Terminated
Location
START
Start Date
2018-02-15
Trial ID
NCT03454243
Treatments Being Tested
The search for clinically actionable alterations within the non-metastatic ...
Status
Not Yet Recruiting
Location
Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Urologia
Start Date
2025-08-05
Trial ID
NCT06875297
Treatments Being Tested
The purpose of the study is to test how well patients with advanced solid t...
Status
Completed
Location
Stanford University
Start Date
2019-09-30
Trial ID
NCT04095273
Treatments Being Tested
This is a randomized, prospective, multicenter, Proof of Concept, Phase II ...
Status
Unknown
Location
OSPEDALI RIUNITI di ANCONA
Start Date
2020-10-07
Trial ID
NCT04591431
Treatments Being Tested
This is a molecular epidemiological investigation aiming to identify micros...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2018-07-11
Trial ID
NCT03596593
Treatments Being Tested
This phase II trial compares atezolizumab in combination with chemotherapy ...
Status
Active Not Recruiting
Location
Kaiser Permanente Dublin
Start Date
2023-12-06
Trial ID
NCT05836584